Figure 7
From: Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
The difference in the serum N-glycans on α-1-acid glycoprotein (AGP) between the PC-ADT and CRPC patients using Gly-Q system. Serum N-glycans on AGP (pooled serum) were measured between the PC-ADT (A) and CRPC (B). The signal area of A3, A4, and A2 were higher in the patients with CRPC (5390 RFU * GU) than that of PC-ADT (4247 RFU * GU) (C). RFU: Relative Fluorescence Unit, GU: Glucose Unit.
